Bernard VERRIER
Equipe : Vecteurs colloïdaux et ingénierie thérapeutique ciblée
Courriel : bernard.verrier@ibcp.fr
Téléphone : +33(0)4-72-72-26-36
Statut : Directeur de recherches
125 publications au total. Seules les 5 dernières années sont affichées
2022
125. Aqueous suspensions of Fuller's earth potentiate the adsorption capacities of paraoxon and improve skin decontamination properties.
Danoy A, Durmaz K, Paoletti M, Vachez L, Roul A, Sohier J, Verrier B
(2022) J Hazard Mater 425 :127714-127714
2021
124. Latent TGF-β Activation Is a Hallmark of the Tenascin Family.
Aubert A, Mercier-gouy P, Aguero S, Berthier L, Liot S, Prigent L, Alcaraz Lb, Verrier B, Terreux R, Moali C, Lambert E, Valcourt U
(2021) Front Immunol 12 :613438-613438
123. LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes.
Ayad C, Libeau P, Lacroix-gimon C, Ladavière C, Verrier B
(2021) Pharmaceutics 13 :
122. Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
Da Costa D, Exbrayat-héritier C, Rambaud B, Megy S, Terreux R, Verrier B, Primard C
(2021) J Nanobiotechnology 19 :12-12
121. Seaweed Sulfated Polysaccharides against Respiratory Viral Infections.
Jabeen M, Dutot M, Fagon R, Verrier B, Monge C
(2021) Pharmaceutics 13 :
120. Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA.
Linares-fernández S, Moreno J, Lambert E, Mercier-gouy P, Vachez L, Verrier B, Exposito Jy
(2021) Mol Ther Nucleic Acids 26 :945-956
119. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.
Liot S, Balas J, Aubert A, Prigent L, Mercier-gouy P, Verrier B, Bertolino P, Hennino A, Valcourt U, Lambert E
(2021) Front Immunol 12 :612271-612271
118. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis.
Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, Lambert E
(2021) Sci Rep 11 :15075-15075
117. Sublingual antigen delivery: a solution for needle-free HIV vaccination.
Monge C, Verrier B
(2021) Expert Rev Vaccines 20 :1047-1050
116. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
Pacheco Y, Valeyre D, El Jammal T, Vallee M, Chevalier F, Lamartine J, Sigaudo-roussel D, Verrier B, Israel-biet D, Freymond N, Cottin V, Calender A
(2021) Cells 10 :
115. Sublingual protein delivery by a mucoadhesive patch made of natural polymers.
Paris Al, Caridade S, Colomb E, Bellina M, Boucard E, Verrier B, Monge C
(2021) Acta Biomater 128 :222-235
114. Sublingual vaccination and delivery systems.
Paris Al, Colomb E, Verrier B, Anjuère F, Monge C
(2021) J Control Release 332 :553-562
113. Biodistribution of surfactant-free poly(lactic-acid) nanoparticles and uptake by endothelial cells and phagocytes in zebrafish: Evidence for endothelium to macrophage transfer.
Rességuier J, Levraud Jp, Dal Nk, Fenaroli F, Primard C, Wohlmann J, Carron G, Griffiths Gw, Le Guellec D, Verrier B
(2021) J Control Release 331 :228-245
2020
112. Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering.
Bekhouche M, Bolon M, Charriaud F, Lamrayah M, Da Costa D, Primard C, Costantini A, Pasdeloup M, Gobert S, Mallein-gerin F, Verrier B, Ducret M, Farges Jc
(2020) J Mater Chem B 8 :8422-8432
111. Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.
Liot S, Aubert A, Hervieu V, Kholti Ne, Schalkwijk J, Verrier B, Valcourt U, Lambert E
(2020) Matrix Biol Plus 6-7 :100021-100021
110. Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam1CSK4 and Pam3CSK4.
Megy S, Aguero S, Da Costa D, Lamrayah M, Berthet M, Primard C, Verrier B, Terreux R
(2020) Nanomaterials (basel) 10 :
2019
109. Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation.
Coolen Al, Lacroix C, Mercier-gouy P, Delaune E, Monge C, Exposito Jy, Verrier B
(2019) Biomaterials 195 :23-37
108. Molecular modelling of TLR agonist Pam(3)CSK(4) entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality.
Lamrayah M, Charriaud F, Hu S, Megy S, Terreux R, Verrier B
(2019) Int J Pharm 568 :118569-118569
107. Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.
Linares-fernandez S, Lacroix C, Exposito Jy, Verrier B
(2019) Trends Mol Med :
2017
106. Tuning the Hydrophilic/Hydrophobic Balance to Control the Structure of Chitosan Films and Their Protein Release Behavior.
Becerra J, Sudre G, Royaud I, Montserret R, Verrier B, Rochas C, Delair T, David L
(2017) Aaps Pharmscitech 18 :1070-1083
105. Nanoparticle-Based Dressing: The Future of Wound Treatment?
Berthet M, Gauthier Y, Lacroix C, Verrier B, Monge C
(2017) Trends Biotechnol 35 :770-784
104. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
Boisgard As, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2017) Eur J Pharm Biopharm 116 :51-60
103. Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing.
Dzikowski M, Castanie N, Guedon A, Verrier B, Primard C, Sohier J
(2017) Int J Pharm :
102. Neutralizing and Targeting Properties of a New Set of α4β7-Specific Antibodies Are Influenced by Their Isotype.
Girard A, Jelicic K, Van Ryk D, Rochereau N, Cicala C, Arthos J, Noailly B, Genin C, Verrier B, Laurant S, Razanajaoana-doll D, Pin Jj, Paul S
(2017) J Acquir Immune Defic Syndr 75 :118-127
101. Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.
Gutjahr A, Papagno L, Nicoli F, Lamoureux A, Vernejoul F, Lioux T, Gostick E, Price Da, Tiraby G, Perouzel E, Appay V, Verrier B, Paul S
(2017) J Immunol 198 :4205-4209
100. Improving bioassay sensitivity through immobilization of bio-probes onto reactive micelles.
Jimenez-sanchez G, Terrat C, Verrier B, Gigmes D, Trimaille T
(2017) Chem Commun (camb) 53 :8062-8065
99. Critical role for skin-derived migratory DCs and Langerhans cells in TFH and GC responses after intradermal immunization.
Levin C, Bonduelle O, Nuttens C, Primard C, Verrier B, Boissonnas A, Combadiere B
(2017) J Invest Dermatol 0 :0
98. Specific and Efficient Uptake of Surfactant-Free Poly(Lactic Acid) Nanovaccine Vehicles by Mucosal Dendritic Cells in Adult Zebrafish after Bath Immersion.
Resseguier J, Delaune E, Coolen Al, Levraud Jp, Boudinot P, Le Guellec D, Verrier B
(2017) Front Immunol 8 :190-190
97. Comparison of four different fuller's earth formulations in skin decontamination.
Roul A, Le Ca, Gustin Mp, Clavaud E, Verrier B, Pirot F, Falson F
(2017) J Appl Toxicol :
96. Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo.
Verrier B, Paul S, Terrat C, Bastide L, Ensinas A, Phelip C, Chanut B, Bulens-grassigny L, Jospin F, Guillon C
(2017) Front Immunol 8 :770-770
95. Ternary polysaccharide complexes: Colloidal drug delivery systems stabilized in physiological media.
Wu D, Ensinas A, Verrier B, Cuvillier A, Champier G, Paul S, Delair T
(2017) Carbohydr Polym 172 :265-274
